Literature DB >> 32514833

Comparative diagnostic accuracy of respective nuclear imaging for suspected fracture-related infection: a systematic review and Bayesian network meta-analysis.

Qingyu Zhang1, Jinlei Dong1, Yelong Shen2, Canhua Yun3, Dongsheng Zhou1, Fanxiao Liu4.   

Abstract

BACKGROUND: The aim of this study was to compare the accuracy of available nuclear imaging modalities in the diagnosis of suspected fracture-related infection (FRI).
METHODS: We conducted a comprehensive literature search of PubMed, EMBASE and the Cochrane Library to retrieve diagnostic accuracy studies in which FRI was investigated using different nuclear imaging modalities. The pooled sensitivity, specificity, likelihood ratios and diagnostic odds ratios were constructed using the bivariate meta-analysis framework, while the superior index was pooled using Bayesian network meta-analysis.
RESULTS: 22 eligible studies (1,565 patients) were included in the quantitative analysis. A broad overlapping confidence interval (CI) of pooled sensitivity was observed among bone scintigraphy (0.94; 95% CI 0.85-0.98), 18F-FDG PET and PET/CT (0.91; 95% CI 0.85-0.94) and leukocyte scintigraphy (0.86; 95% CI 0.53-0.97). Bone scintigraphy (0.34; 95% CI 0.08-0.75) seemed to be less specific than all the other modalities, while leukocyte scintigraphy (0.96, 95% CI 0.92-0.98) was notably more specific than 18F-FDG PET and PET/CT (0.78; 95% CI 0.69-0.85). Based on the superiority index, 18F-FDG PET/CT (3.78; 95% CI 0.14-11.00), 18F-FDG PET (2.98; 95% CI 0.14-9.00) and leukocyte scintigraphy (1.51; 95% CI 0.11-7.00) all achieved high accuracy in detecting FRI.
CONCLUSION: Bone scintigraphy is a highly sensitive nuclear imaging technique but lacks the specificity needed to unequivocally differentiate among various conditions suspected to be FRI. Leukocyte scintigraphy, 18F-FDG PET/CT and PET all present good satisfactory accuracy for the diagnosis of FRI, but their costs should be further reduced to promote their wide application.

Entities:  

Keywords:  Bayesian meta-analysis; Fracture-related infection; Nuclear imaging

Mesh:

Substances:

Year:  2020        PMID: 32514833     DOI: 10.1007/s00402-020-03506-3

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  50 in total

1.  Laboratory-based versus qualitative assessment of α-defensin in periprosthetic hip and knee infections: a systematic review and meta-analysis.

Authors:  Giovanni Balato; Vincenzo de Matteo; Tiziana Ascione; Sigismondo Luca Di Donato; Cristiano De Franco; Francesco Smeraglia; Andrea Baldini; Massimo Mariconda
Journal:  Arch Orthop Trauma Surg       Date:  2019-07-12       Impact factor: 3.067

2.  Infection rates after open tibial fractures: are they decreasing?

Authors:  Ioannis Ktistakis; Marilena Giannoudi; Peter V Giannoudis
Journal:  Injury       Date:  2014-04-03       Impact factor: 2.586

3.  Histological score for degrees of severity in an implant-associated infection model in mice.

Authors:  Carina Büren; Michael Hambüchen; Joachim Windolf; Tim Lögters; Ceylan Daniela Windolf
Journal:  Arch Orthop Trauma Surg       Date:  2019-04-24       Impact factor: 3.067

4.  Increased perioperative C-reactive protein and decreased postoperative albumin is associated with acute posttraumatic osteomyelitis in patients with high-energy tibial fractures.

Authors:  Matjaž Groznik; Matej Cimerman; Lara Lusa; Nina Ružić Gorenjec; Alojz Ihan
Journal:  Injury       Date:  2019-03-05       Impact factor: 2.586

5.  Fracture-related infection: A consensus on definition from an international expert group.

Authors:  W J Metsemakers; M Morgenstern; M A McNally; T F Moriarty; I McFadyen; M Scarborough; N A Athanasou; P E Ochsner; R Kuehl; M Raschke; O Borens; Z Xie; S Velkes; S Hungerer; S L Kates; C Zalavras; P V Giannoudis; R G Richards; M H J Verhofstad
Journal:  Injury       Date:  2017-08-24       Impact factor: 2.586

6.  Open extremity fractures: impact of delay in operative debridement and irrigation.

Authors:  Ajai Kumar Malhotra; Stephanie Goldberg; Jeffery Graham; Nancy R Malhotra; Mark C Willis; Varatharaj Mounasamy; Kelly Guilford; Therese M Duane; Michel B Aboutanos; Julie Mayglothling; Rao R Ivatury
Journal:  J Trauma Acute Care Surg       Date:  2014-05       Impact factor: 3.313

7.  Surgical site infection in orthopedic trauma: A case-control study evaluating risk factors and cost.

Authors:  Rachel V Thakore; Sarah E Greenberg; Hanyuan Shi; Alexandra M Foxx; Elvis L Francois; Marc A Prablek; Samuel K Nwosu; Kristin R Archer; Jesse M Ehrenfeld; William T Obremskey; Manish K Sethi
Journal:  J Clin Orthop Trauma       Date:  2015-06-18

Review 8.  Accuracy of diagnostic imaging modalities for peripheral post-traumatic osteomyelitis - a systematic review of the recent literature.

Authors:  Geertje A Govaert; Frank F IJpma; Martin McNally; Eugene McNally; Inge H Reininga; Andor W Glaudemans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-27       Impact factor: 9.236

9.  Orthopaedic device-related infection: current and future interventions for improved prevention and treatment.

Authors:  T Fintan Moriarty; Richard Kuehl; Tom Coenye; Willem-Jan Metsemakers; Mario Morgenstern; Edward M Schwarz; Martijn Riool; Sebastian A J Zaat; Nina Khana; Stephen L Kates; R Geoff Richards
Journal:  EFORT Open Rev       Date:  2017-03-13

10.  Diagnosing Fracture-Related Infection: Current Concepts and Recommendations.

Authors:  Geertje A M Govaert; Richard Kuehl; Bridget L Atkins; Andrej Trampuz; Mario Morgenstern; William T Obremskey; Michael H J Verhofstad; Martin A McNally; Willem-Jan Metsemakers
Journal:  J Orthop Trauma       Date:  2020-01       Impact factor: 2.884

View more
  1 in total

Review 1.  Fracture-related infection.

Authors:  T Fintan Moriarty; Willem-Jan Metsemakers; Mario Morgenstern; Marloes I Hofstee; Alejandro Vallejo Diaz; James E Cassat; Britt Wildemann; Melissa Depypere; Edward M Schwarz; R Geoff Richards
Journal:  Nat Rev Dis Primers       Date:  2022-10-20       Impact factor: 65.038

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.